top of page

Impavido® (miltefosine) is an FDA-approved treatment for cutaneous,  mucosal and visceral leishmaniasis in patients 12 years of age and older. PLEASE SEE FULL PRESCRIBING INFO

BY KIANA COLE kmcole@charlotteobserver.com

Writer
More actions
bottom of page